Showing posts with label Case Study. Show all posts
Showing posts with label Case Study. Show all posts

Tuesday, September 16, 2008

Later Use of Clot-Buster After Stroke Possible: Study

(HealthDay News) -- European researchers who showed that the clot-dissolving drug tPA could safely be used within three hours after a stroke now say the limit can be extended to four-and-a-half hours.

"We now have a three-hour limit mandated by authorities," said Dr. Nils Wahlgren, a neurology professor at the Karolinska Institute in Sweden and leader of an international group reporting Sunday in the online version of The Lancet. "Our data indicate that it is safe to extend that from three hours to four-and-a-half hours. The risk of hemorrhagic complications is not significantly different from the earlier time limit."

Tissue plasminogen activator (tPA), also known as the drug alteplase, is the approved treatment for the most common kind of stroke, in which a blood clot blocks a brain artery. The three-hour post-stroke time limit has been set because of fears that use of the clot-dissolving drug beyond that period might cause dangerous bleeding or other complications.

The new report is the latest from a study requested by European authorities after doubts arose about the safety of tPA in stroke treatment, which was approved in 1996 by the U.S. Food and Drug Administration. It was approved in 2002 in Europe.

The study compared the outcomes of 664 people who were given tPA between three and four-and-a-half hours after a stroke against almost 12,000 who received the drug within three hours of an attack.

The study found a death rate of 12.7 percent in the following three months for the three-hour group and 12.2 percent for those getting tPA later. In the early group, 58 percent achieved the ability of independent action, compared to 56.3 percent in the later-administration group.

"We recorded no significant differences between the 3- to 4.5-hour cohort and the within 3-hour cohort for any outcome measure," the researchers reported.

The bottom line, according to Wahlgren: "if patient treatment has been delayed, it is still safe to treat a patient beyond the time limit of three hours."

The results were expected to be presented at an international meeting in Stockholm in November, "when we will recommend a change in the guidelines," Wahlgren said. "I expect it would be accepted by the international community, both in the United States and Europe, and in the rest of the world."

But the new results do not necessarily mean an end to the three-hour limit, cautioned Dr. Larry Goldstein, professor of neurology at Duke University and director of the Duke Stroke Center in Durham, N.C.

"They are consistent with a combined analysis done some time ago that suggested we might be able to treat beyond three hours," Goldstein said. "But those were observational studies, as was this one. Controlled trials done to test that belief have not shown benefit."

It will take a change in the current guidelines to alter the three-hour limit, he said, and the overall benefit of tPA is greater when it is given earlier. "The sooner you get blood to the brain, the better," Goldstein said.

More information
There's more on tPA at the American Heart Association.

Saturday, June 28, 2008

Do Difficult Patients Get Bad Medical Care?

By Dena Rifkin, MD

A question that has received a lot of attention in the doctor community is whether patient attitude affects the quality of care they receive. In an effort to tackle it, let’s take a look at two of my past patients.
Case Study #1: No matter how late I was to see him, or how bad the news was when I did see him, Mr. X was unflaggingly polite. He had a quiet, gentle voice, and his “Yes, doctor” and “Thank you, doctor” responses were kind and reassuring. He is the only patient who ever thanked me for offering him dialysis. He chose home dialysis, learning the mechanics of the system quickly and managing the multiple medications we prescribed without any problems. Read More

Friday, February 29, 2008

Heart Hormones Beat Back Cancers in Mice

(HealthDay News) -- New research offers early evidence that hormones produced by the heart to control both blood pressure and volume could be harnessed to treat -- and possibly cure -- a wide range of cancers.

Following a month of intravenous treatment with any of four human cardiac peptide hormones, mice engineered to develop human pancreatic and breast cancer experienced dramatic results:

On average, 54 percent of those with breast cancer and 37 percent of those with pancreatic cancer were cured, without tumor recurrence or treatment side effects.

Even tumor shrinkage among non-cured mice was striking, with size reductions of 90-plus percent. And a more detailed analysis, hormone-by-hormone, revealed even stronger anti-cancer properties among certain hormones. In such best-case scenarios, the most effective hormones provoked full tumor elimination -- without surgery, chemotherapy or any other additional treatment -- in two-thirds of the mice with breast cancer and 80 percent of the mice with pancreatic cancer.

"This raises hope for turning cancer -- even when not fully cured -- into a chronic disease," said study author Dr. David L. Vesely, director of the department of molecular pharmacology and physiology at the University of South Florida's Cardiac Hormone Center, in Tampa.

Vesely is scheduled to present his findings April 9 at the Experimental Biology annual conference in San Diego. The findings were originally published in the journal in vivo last year.

"For 350 years, the heart has been thought of simply as a pump," Vesely said. "But we now know it makes hormones that lower your blood pressure and get rid of salt and water. So, first we took four of them that all come from the same gene, and looked at them in laboratory cell cultures, and found that they essentially eliminated 97 percent of exposed cancer cells within 24 hours."

With funding largely from the U.S. Veteran's Administration, the research team then grew human cancer cells in 1-month-old male and female mice, focusing first on pancreatic cancer, which Vesely described as the "worst of all," given the fast pace of its development, its poor treatment track record, and a mean survival rate of just four months.

Nearly 34,000 Americans are diagnosed with pancreatic cancer each year, and 32,000 die of the disease annually.

Some of the pancreatic cancer mice received a saline solution, while others were exposed to a month-long regimen of one of four cardiac hormones: long acting natriuretic peptide (LANP), vessel dilator (VDL), kaliruretic peptide (KP), or atrial natriuretic peptide (ANP).

ANP was found to provide the best anti-cancer effect, eliminating tumors in four of five treated mice. Among those not fully cured, VDL provided the best cancer reduction -- bringing exposed tumors down to just 2 percent of their largest size.

After a year, the researchers found that all the cured mice remained cancer-free. Based on the fact that the normal life span for a mouse is about one year, Vesely and his colleagues concluded that all the treated mice ended up dying of old age, not cancer.

Vesely, who noted that his wife died of breast cancer about five years ago, then turned his focus to that cancer.

He said that in similar mouse experiments, treatments with VDL and KP hormones both produced a 67 percent tumor elimination rate.

"We never expected results this good, of course," he said. "And I don't want to get too carried away here. But if this works in humans, it would be spectacular. Because, of course, one out of every two families [experiences] cancer."

Human trials -- funded by the private San Diego-based firm Kalos Therapeutics -- are to begin within 12 to 18 months. If all goes well, Vesely predicted that a hormone treatment could become available within three years.

However, Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society, cautioned that while the notion of a heart hormone cancer treatment has a "seductive" appeal, much more research is required.

"Unfortunately, in general, we see a lot of experiments that seem promising in test tubes and animals but for whatever reason don't translate into anything that has treatment benefit," he said. "And specifically, in this case, we're talking about normal hormones already in circulation in our body, and normal receptors on cancer cells.

"So, in a perhaps simplistic, but nonetheless important, way, the question then arises: Why do people get cancer in the first place if this hormonal mechanism is so effective?" Lichtenfeld said. "And I do not see that the researchers clearly suggest an underlying rational mechanism to explain why this would happen and work in humans.

"So, I understand here that a researcher has lost a wife and a mother to cancer, and I know it's personal," he acknowledged. "And I've certainly learned to never say never. But it would take considerably more replication of this work before I could say this theory will gain traction."

More information
For additional information on current cancer treatment options, visit the American Cancer Society.


Balancing Your Hormones Without Drugs... You Can Feel Good Again

Balancing Your Hormones Without Drugs... You Can Feel Good Again

$19.95
[ learn more ]

Add to Cart

Hormone imbalance can be reversed! Look and feel better than ever, just take the time to learn about yourself and read the information contained in this just released e-book about reversing hormone imbalance. Are you ready to finally look and feel great? If so... read on... - E-Book Version.(BH)

Thursday, February 14, 2008

Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems

(HealthDay News) -- Multiple sclerosis patients who smoke marijuana in search of symptom relief are more likely to suffer cognitive shortfalls and mood disorders, new Canadian research suggests.

A slowing down in the ability to process and remember information is one significant side effect, as is a rise in the rate of depression and anxiety.

"This is a small study, so our findings are preliminary, but the bottom line is that multiple sclerosis patients who smoke cannabis appear to be at an increased risk for cognitive issues, particularly with respect to the speed of their thinking," said study author Dr. Anthony Feinstein, a professor of psychiatry with the Sunnybrook Health Sciences Centre's department of psychiatry at the University of Toronto.

Feinstein's observations are published in the Feb. 13 online edition of Neurology and are focused exclusively on the impact of smoking marijuana illegally obtained by patients themselves. Medically prescribed marijuana was not studied.

The authors noted that a "significant minority" of multiple sclerosis patients smoke marijuana to combat the tingling, numbness, blindness and paralysis that can accompany the progressive and often disabling nervous system disease.

However, Feinstein's team stressed that scientists have yet to definitively prove that the psychoactive substance -- long linked to psychosis, anxiety and delirium among healthy users -- provides a measurable benefit to the more than 400,000 Americans and 2.5 million people worldwide who suffer from the disease.

The researchers therefore assessed the experience of 140 Toronto-based MS outpatients, 10 of whom had smoked the drug at least once in the previous month and were considered regular marijuana users.

All the patients -- three-quarters of them women -- underwent cognitive and mental health exams by a neurologist and a neuro-psychiatrist. Interviews were also conducted to assess disease severity and course, medications being used, and current disability.

Feinstein and his team observed that while pot smokers were younger, there were no differences between marijuana users and nonusers in terms of gender, education, or MS disease course or duration.

However, MS patients who used marijuana were found to perform 50 percent slower on tests tracking information-processing speed and were more likely than nonusers to have a mental disability of some kind.

Marijuana use was also associated with a greater risk for being depressed or experiencing anxiety. However, the authors were not able to determine whether the drug had triggered such conditions, or if patients had sought out marijuana to help deal with a preexisting emotional issue.

They nonetheless cautioned that smoking marijuana might further raise the risk for experiencing the kind of neuro-psychological impairment that typically occurs among 40 percent to 65 percent of all MS patients.

Feinstein said that he next hopes to gather a much larger pool of patients, while exploring possible differences in the health impact of street-purchased marijuana versus prescribed cannabis.

Meanwhile, Dr. Marshall Keilson, director of neurology at Maimonides Medical Center in Brooklyn, N.Y., said he thinks it best to proceed on a case-by-case basis.

"There are some MS patients who are emotionally disabled from their disease, and if we can use cannabis to help them feel better about the world or life, we should," he said. "We need to always err on the side of doing what's best for our patients. And I don't necessarily believe there is a permanent damage to the brain, based on occasional marijuana use. If they're smoking 10 times a day, yes, there will be damage done. But this goes for excessive alcohol use, too. So, I think we're going to end up somewhere in the middle with this."

More information
For more on multiple sclerosis, visit the National Multiple Sclerosis Society.

Friday, December 07, 2007

Blackberries, Broccoli Sprouts Battle Cancer

(HealthDay News) -- Your local farmer's market might hold the key to cancer prevention, since new research shows that black raspberries, broccoli sprouts and some raw vegetables reduce the risk of esophageal and bladder cancers.

Data from three studies on the subject was presented Thursday at the American Association for Cancer Research's Sixth Annual International Conference on Frontiers in Cancer Prevention, in Philadelphia.

Fruits and vegetables have long been known to help reduce the risk of certain cancers. Based on prior research, the American Cancer Society recommends eating five servings of fruits and vegetables daily.

In the first study, Ohio State University researchers found black raspberries may protect against esophageal cancer by reducing the oxidative stress that results from Barrett's esophagus, a precancerous condition usually caused by gastroesophageal reflux disease. The esophagus is a long tube that connects the throat to the stomach. Reflux disease causes stomach acid to continually splash back up into the esophagus.

"Specifically in the case of Barrett's patients, reflux of the stomach and bile acid contribute to ongoing oxidative damage. Thus, our hypothesis is that feeding a food that is high in potential protective constituents, such as antioxidants, vitamins, minerals and other phytochemicals, may help restore the oxidative balance," lead researcher Laura Kresty said.

People with Barrett's esophagus typically are 30 to 40 times more likely to develop esophageal cancer, which has a poor five-year survival rate of 15 percent.

The team gave 32 grams to 45 grams of black raspberries daily for six months to 20 patients with Barrett's esophagus. They analyzed changes in blood, urine and tissue before, during and after the treatment, and found lower levels of some of the chemical markers of oxidative stress in both urine and tissue samples.

Black raspberries previously have been shown to reduce the risk of oral, esophageal and colon cancer in animal models, according to the researchers, who called for further study in humans.

Dietitian Wendy Demark-Wahnefried, a professor of behavioral science at M.D. Anderson Cancer Center at the University of Texas in Houston, said she would feel comfortable advising people with Barrett's to eat black raspberries. "It couldn't hurt," she said, but added that further studies need to find out if the berries really do prevent cancer.

In other research presented at the meeting, broccoli sprouts and cruciferous vegetables both showed promise in the fight against bladder cancer, according to two separate teams from the Roswell Park Cancer Institute in Buffalo, N.Y.

Using a rat model, a team lead by Dr. Yuesheng Zhang, a professor of oncology, demonstrated that a broccoli sprout extract reduced bladder cancer in rats by 70 percent.

"Our present study shows that broccoli sprout extracts fed to rats in the diet inhibits bladder cancer development induced by a carcinogen. We don't yet know if the extracts inhibit the growth of a existing bladder cancer," said Zhang, who explained that broccoli sprouts are a rich source of a well-known cancer preventive agent known as sulforaphane.

"We next plan to find out if broccoli sprout extracts can fight bladder cancer in humans," Zhang noted.

A second team at the institute found that people who ate three or more servings of raw, cruciferous vegetables per month reduced their risk of bladder cancer by 40 percent.

Cruciferous vegetables include broccoli, cabbage and cauliflower.

The team analyzed the dietary habits of 275 people with early bladder cancer and 825 people who were cancer-free. The researchers specifically asked how many servings of raw or cooked cruciferous vegetables they ate before their diagnosis and whether they smoked.

Analysis of the data showed that the more raw, cruciferous vegetables people ate, the lower their risk of bladder cancer. In comparison to people who smoked and ate fewer than three servings of raw vegetables a day, nonsmokers eating at least three servings of cruciferous vegetables daily were 73 percent less likely to develop bladder cancer.

"In our study, we do find intake of raw cruciferous vegetables showed risk reduction of bladder cancer in smokers, and even the heavier smokers," said lead researcher Li Tang.

The researchers stressed that the benefits are derived from raw cruciferous vegetables, giving cole slaw the edge over cabbage soup when it comes to cancer prevention.

"This confirms that there are a variety of compounds within fruits and vegetables that contribute to reducing the risk of cancer. Research like these studies contribute to our knowledge about what the impact of specific nutrients may be on specific types of cancer," said Colleen Doyle, director of nutrition and physical activity for the American Cancer Society.

"Cooking leaches out some nutrients but makes others more absorbable. Until we know more in this regard, the bottom-line message for consumers is eat at least five servings of fruits and vegetables each day, raw and/or lightly cooked. Focus on those with the most color, since, in general, fruit and vegetables with the most color have the most cancer-fighting antioxidants and phytochemicals."

"Surveys we've done indicate many people don't think they have control over their cancer risk, but studies clearly indicate they do. For the majority of people who don't smoke, watching their weight, being more active and eating a healthy diet are the most important ways to reduce cancer risk," Doyle said.

More information
To learn how diet and physical activity can help prevent cancer, visit the American Cancer Society.






Oxy-Powder® Complete Cleansing System

Oxy-Powder® Complete Cleansing System

$147.75
[ learn more ]

Add to Cart

Complete Cleansing System with Livatrex™, Oxy-Powder®, Latero-Flora™, and two bottles of ParaTrex®.

Sunday, September 02, 2007

Scientists ID Likely Culprit in 'Popcorn Lung'

(HealthDay News) -- A key chemical ingredient in the buttery flavoring of microwave popcorn has been identified as a likely culprit in "popcorn lung," a lung disease that afflicts people who work in the microwave popcorn manufacturing industry, Dutch researchers report.

Publishing in the September issue of the American Journal of Respiratory and Critical Care Medicine, the team said that the chemical diacetyl may be responsible for more cases of bronchiolitis obliterans syndrome (BOS), otherwise known as "popcorn lung," at a diacetyl factory.

"Our study found a cluster of [previously undiagnosed] BOS cases in a diacetyl production plant," lead author Dr. Frits van Rooy, of the Division of Environmental Epidemiology at the Universiteit Utrecht, said in a prepared statement. "This supports the conclusion that an agent in the diacetyl production process has caused BOS."

The disease was first noticed in 2001 among workers at an American plant that made microwaveable popcorn. Diacetyl was identified early on as an indicator of exposure, but the chemical's role in the development of the lung disease was not known.

The research team in the Netherlands traced 196 former workers who were still alive and had been employed at the diacetyl production plant between 1960 and 2003. They identified 175 who agreed to fill out exposure and respiratory health questionnaires. The workers also took lung function tests and completed clinical assessments. Four cases of "popcorn lung" were identified in the 102 workers thought to be at risk for high exposure.

The authors noted that this was the first study of lung health among workers for a plant producing diacetyl. They acknowledged that they could not rule out the impact of other chemicals made at the same plant, but the data created a stronger case for diacetyl as a possible cause of "popcorn lung." Acetoin and acetyldehyde may also contribute, the researchers said.

An editorial accompanying the journal article expressed concern over the fact that none of the four cases had been diagnosed as an occupationally related lung disease or bronchiolitis obliterans specifically prior to the study.

More information
To learn more about bronchiolitis obliterans, visit Haz-Map: Occupational Exposure to Hazardous Agents.

Friday, July 20, 2007

Genetic Analysis Offers Insights Into AIDS Resistance

(HealthDay News) -- Variations in three genes play a critical role in how different people infected with HIV respond during the early stages of their infection.

This finding, detailed in the July 20 issue of Science, could help scientists find vaccines as well as new treatment targets for people infected with the AIDS-causing virus.

"There are new mechanisms of control of HIV1 that are implicated by these findings," said study senior author David Goldstein, a professor of molecular genetics and microbiology at Duke University and director of the school's Center for Population Genomics and Pharmacogenetics.

"We don't yet know how to capitalize on those new mechanisms to develop new treatments, but it establishes directions for exploring new treatment options."

The study results are the first to emerge from the Center for HIV/AIDS Vaccine Immunology (CHAVI), a seven-year project funded by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) with a goal of understanding the genetic influences on early responses to HIV infection. Many more studies are planned.

"We're really only just getting started," Goldstein said.

"It is a very important study," said NIAID Director Dr. Anthony Fauci. "It's significant for a couple of reasons. First of all, it used a technique that is going to be increasingly used in the genetics of medicine and that is to do a genome-wide association study to try and identify genes or modifications of genes which we call polymorphisms that are associated with certain expression of disease."

People infected with HIV have widely varying responses to their infection, with some falling sick quickly and others successfully fighting off full-blown AIDS for years or even decades.

One measurable difference is the level of circulating virus in the blood during the "stable" period after a person is infected but before he or she develops symptoms. This "viral load" is generally an indication of how well the person's immune system is fighting off the infection.

The new study searched for genetic differences that might explain variations in viral loads.
"One of the big questions in HIV is what are the determinants of the great variability in individuals being able to handle the virus. That's a big, big open question," Fauci said. "One of the ways to address that is to say look, there are some people whose viral set point, the level at which the body holds the virus in the absence of therapy, that varies enormously from person to person. We have no idea why that's the case. This study came up with three gene polymorphisms which appear to be associated very strongly with the ability to set the viral load.

The combination of those explains about 15 percent of the variation in viral load among patients."

"The approach that we've taken is to use these natural differences among individuals in how well they can control the virus after infection as a pointer to new ways to act against the virus," Goldstein said. "That variation is huge. Some can push viral levels so low they will never progress to AIDS, whereas others can hardly contain it."

It took the international team of geneticists 18 months to identify the three crucial genes. In the end, they identified 486 appropriate patients from a possible universe of 30,000 people worldwide, and did genome-wide scanning on these patients. The study participants could not be undergoing treatment (as this would affect viral load levels), they had to know when they became infected, and there had to be high-quality laboratory estimates of their viral load.

This was the first time a genome-wide approach has been used for an infectious disease, the researchers said.
Two of the gene variants -- or polymorphisms -- were found in genes controlling the human leukocyte antigen (HLA) system, which helps identify foreign invaders and tags them for destruction. These genes, HLA-A and HLA-B, are switched off by HIV when it enters the body so the immune system is no longer able to recognize the virus as foreign.

Research published in the May 13 issue of Nature Genetics also implicated the HLA-B gene. That study found that HLA-B, in combination with another gene, KIR3DL1, might confer some protection against AIDS progression.

But HIV doesn't seem to be able to shut off HLA-C, the third gene variant identified by the researchers behind the new study. "This had not been a focus of attention in the past because it was not known that it is important in the control of HIV," Goldstein said. "We've now implicated this part of the immune response as being important so it now becomes a focus."

"It might be that this gene represents a vulnerable point for HIV," he added. "As far as we know, HIV can't act against it."
The three gene variants identified in the study explain 15 percent of the variability in how well people contain their viral load. "In genetic terms, that's a lot," Goldstein said. "These are very important genetic effects."

The next CHAVI study will look at what factors might protect people from becoming infected with HIV in the first place.

More information
Visit CHAVI for more on cutting-edge HIV/AIDS research.

Thursday, May 17, 2007

Emergency Room HIV Tests Cost-Effective: Study

(HealthDay News) -- Routine HIV screening in hospital emergency departments is cost-effective and actually welcomed by many patients, a George Washington University Medical School study finds.

More than 4,000 patients were offered the screening and almost 2,500 (60 percent) agreed to be tested. Of those, 26 patients (one percent) had a preliminary positive result for HIV infection.

HIV is the virus that causes AIDS.

The rapid screening kits were provided free of charge by the Washington, D.C., Department of Health, while researchers did the actual clinical work. While this approach would not be feasible over the long-term, it does suggest some models for a program of ongoing HIV testing in hospital emergency departments, said study author Jeremy Brown, research director in the university's department of emergency medicine.

He said the cost per preliminary positive HIV result was about $1,700, and about $4,900 per confirmed case of HIV infection.

"Washington, D.C., has one of the highest AIDS case prevalence rates in the United States, and our results suggest that ED HIV screening in this high prevalence area is well accepted by patients," Brown noted.

"The cost per case detected is low when compared with other methods for the early detection of HIV. For example, nucleic acid amplification has been used (for) early detection of HIV infection at a cost of over $17,000 per index case identified."

The study was expected to be presented May 16 at the annual meeting of the Society for Academic Emergency Medicine, in Chicago.

More information
The U.S. Centers for Disease Control and Prevention has more about HIV testing.

Wednesday, April 18, 2007

Multiple Sclerosis Drug Combats Vision Loss

(HealthDay News) -- A controversial multiple sclerosis drug called Tysabri also reduces vision loss associated with the disease by 47 percent, a new study found.

"Vision loss is probably one of the most disabling things that happens to people with MS," said lead researcher Dr. Laura J. Balcer, an associate professor of neurology at the University of Pennsylvania School of Medicine. "The exciting thing is, first, that we now have an eye-chart test that can pick that up and can show if treatments help vision. Second, this particular drug appears to help prevent vision loss."

In the study, Balcer's group looked at the results of two trials -- called AFFIRM and SENTINEL -- that included 2,138 people with relapsing MS. More than half the patients received Tysabri (generic name natalizumab) every four weeks for two years.

To evaluate eyesight, the researchers used a specially developed eye chart of low contrast letters. They found vision loss was reduced by as much as 47 percent among the people taking Tysabri, compared with those taking a placebo.

"Vision is one more dimension of MS that the drug helps," Balcer said. "It has already been shown that the drug reduces the rates of relapses and disability."

Balcer thinks that other MS drugs may have similar effects on vision, and there is now a test that can be included in trials to evaluate this. "Now, we can get to see how these other medications may help vision," she said.

The findings are published in the April 17 issue of the journal Neurology.

Tysabri's history has been marked by some controversy.

It received U.S. Food and Drug Administration approval in November 2004, only to be pulled from the market three months later after several patients in clinical trials developed a rare but deadly viral infection of the brain called progressive multifocal leukoencephalopathy. In June 2006, the FDA allowed the drug to return to the mart, but with strict conditions. According to the new guidelines, Tysabri can only be administered by approved doctors, infusion sites and pharmacies that register and comply with a patient-safety program designed by Biogen-IDEC, the maker of Tysabri, and approved by the FDA.

One expert thinks that despite the vision benefit, Tysabri should be reserved for patients with aggressive MS or those who failed other medications.

"This study confirms the benefits of this particular MS drug in relapsing MS patients," said Dr. Anne H. Cross, a professor of neurology at Washington University School of Medicine, in St. Louis. "In addition, it validates the use of a new vision test which is relevant to MS."
But the benefit to vision doesn't negate the risks associated with the drug, Cross said. "I don't think I will change my prescribing habits based upon this paper," she said. "I will probably continue to use it in the same type of patients I have been using it in in the past."

However, Nicholas LaRocca, the director of health care delivery and policy research at the National Multiple Sclerosis Society, said the new study provides additional insight into the benefits of the drug and may influence the decision whether to start using it or not.
"For patients who are on natalizumab or considering natalizumab, this gives them another piece of information to consider as they are trying to make their decision," he said.

According to the U.S. National Institutes of Health, multiple sclerosis is an unpredictable disease of the central nervous system that can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many researchers believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault.

More information
http://www.dreddyclinic.com/findinformation/mm/multiplesclerosis.htm

Friday, January 26, 2007

Steam & Sauna Bathing Offers Multiple Rejuvenating & Healing Benefits

Written by The International Steam Therapy Association

Part 1
Most people laugh when they hear that the Finnish Olympic team lugs a portable sauna with them wherever they go. However, the fair-haired Nordic athletes might be doing more than simply acting out a home-sick longing for the slender birch trees and island dotted lakes of the homeland. They could be on to a secret, non-drug-induced means of giving themselves an edge in the fierce competition of modern-day Olympics.
Although most people simply consider it a pleasant means of relaxation, sweat therapy might in fact have powerful heath-enhancing effects.

In the test of time is any measure, steam bathing has certainly withstood it. For thousands of years people of all cultures have indulged in the soothing warmth of sweat baths. The Romans are well-known for their elaborate baths. The wealthy of 200 B.C. India did not consider their mansion complete unless it included a bathhouse with a steam room. The Muslim Hamman, or bathhouse, with its domed, central steam chamber is stall an integral part of life in Muslim countries. A derivation of the Hamman, the Turkish bath, has been popular in Europe for centuries.

Today, steam and sauna facilities are an integral part of the hydrotherapeutic offerings at European and American spas, and steam rooms and saunas are a common feature of health clubs and public pools. Yet, there is surprisingly little awareness of the wide ranging benefits of steam and sauna bathing. There is evidence that these sweat-inducing treatments stimulate the immune system, improve circulation, and help the body to purge itself of impurities.
Hippocrates, the founder of Western medicine more than two-thousand years ago said, "Give me the power to create a fever, and I shall cure any disease."

Although often misunderstood as a symptom of disease, fever actually is a part of the body's natural healing response. Steam baths, sauna, and other heat-inducing treatments elicit similar healing responses in the body, and consequently are often called "artificial fevers".

During a fever, the functioning of the immune system is stimulated, while the growth of bacteria and virus is forced to slow down. The production of white blood cells, the primary agents of the immune system, is increased, as is the rate of their release into the blood stream. The generation of antibodies speeds up, as does the production of interferon, an anti viral protein that also has powerful cancer-fighting properties.

Apart from stimulating the immune system, fever slows down the proliferation of invading organisms by creating an inhospitable environment. At 104 degrees F., for example, the growth rate of the polio virus is reduced up to 250 times; at 106 degrees pneumococcus, a bacterium responsible for pneumonia, dies.

Part 2
Before the advent of antibiotics, syphilitics were often infected with malaria to prevent the spread of the disease. In addition, there is evidence that the frequent fevers of malaria might function as a cancer-protecting factor. Dr. Paavo Airola in his book, Worldwide Secrets of Staying Young relates the story of the Pontine swamps near Rome in Italy, which, until a few decades ago, were a breeding ground for malaria-carrying mosquitoes. The swamps were dried out, and the malaria disappeared. However, during the next decades, that area, which had before been almost free of cancer, saw an increase in cancerous diseases. After a generation, the cancer incidence level of that area had reached the level of the rest of Italy.

Malignant cells are selectively destroyed at temperatures of 106 to 110 degrees F., so the frequent fever attacks of people in the malaria-infected area might have mobilized the body's own defenses too frequently for a cancer to take hold.

Although the artificial fever induced by sweat therapy does not have the comprehensive effect of real fever, it still produces a striking effect on a number of bodily processes.

There is evidence that artificial fever works as an immune system stimulant by increasing the number of white blood cells in the body. In a 1959-review of studies on the effects of heat treatments, Mayo Clinic researcher Dr. Wakim and colleagues cite findings indicating that the number of white blood cells in the blood increased by an average of 58% during artificially induced fever. Researchers also have found increases in the activity of the white blood cells during induced fever.

In addition, as in the case of bodily induced fever, the raised temperature during the artificial fever reduces the growth rate of most bacteria and viruses, giving the immune system time to mobilize its own forces. Indeed, many regular steam or sauna bathers have experienced that a good, long sweat bath at the early onset of a cold or flu can help ward off the disease before in manifests as actual symptoms.

Apart from the immune system-stimulating effects of sweat therapy, many thought it as one of the most effective and painless detoxifying treatments available.

Dr. Veronica Butler, medical co-director at the Raj, a health center based on principles of Ayurveda, recommends herbalized steam baths, called swedenas, to clients as part of the ancient Ayurvedic purification treatment, known as panchakarma.

According to the classical Ayurvedic texts, for maximum results, a swedena or steam bath should be given while keeping the head cool and the client supine.

"A swedena clears the shrotas, the channels through which the biological intelligence flows," says Dr. Butler. "If impurities clog these channels, the flow of intelligence in the body becomes more susceptible to disease."

Part 3
Heat speeds up the chemical processes in the body, making steam and sauna bathing one of the simplest and most comfortable ways to rid the body of accumulated toxins. As the pores open up and the million of sweat glands start to excrete, the body rids itself of metabolic and other waste products. Sweat contains almost the same elements as urine, and for this reason, the skin is sometimes called the third kidney. It is estimated that as much as 30% of bodily wastes are eliminated by way of perspiration.

However, more than common metabolic waste products are secreted through the skin. Natural health practitioners often notice that when heavy smokers get a steam bath for a body wrap (where the body 'simmers' for up to 45 min. Under hot covers), they will leave a yellow residue on the towels. Reino Tarkianinen, President of Finlandia Sauna, reports that when the company replaces sauna benches from public baths, a thick, black layer of accumulated tar can be found underneath the benches.

In Finland, research is being done on the use of sweat therapy in the treatment of people who are chemically affected. The purifying effects of perspiration could also be behind claims that steam and sauna treatments can help cur or control such ailments as acne and arthritis.

Last but not least, steam and sauna bathing produces powerful therapeutic effects simply by increasing circulation. As the carrier of the rebuilding forces of the nutrients to all parts of the body, the bloodstream plays a crucial role in the maintenance of health.

Steam and sauna treatments have a stimulating effect on the cardiovascular system. The pulse rate increases from 75 beats per minute to between 100-150 beats per minute during a 15-20 minute treatment. This increases blood circulation, but not blood pressure, since the heat also causes the tiny blood vessel in the skin to expand, accommodating the increased blood flow. The dilation of the capillary vessels enables the bloodstream to carry great amounts of nutrients to the skin, enhancing the nutritive status of the skin. The flushed, youthful look that steam and sauna bathers maintain for up to several hours after treatment is due to this effect.

Which is the best way of taking a steam or sauna treatment?
First of all, it is good to be aware of the distinction between the two. Most people think of the heat of a sauna as dry heat and the heat of a steam room as wet, humid heat. This distinction is only partially correct. Sauna bathers in Finland splash water on the heated stones in the sauna, raising the humidity level to as much as 40%. Without that, the hot, dry sauna air can irritate the mucus membranes.

Part 4
In the hydrotherapeutic tradition used at European and America spas, sweat therapy is used in preparation for massage as a means of increasing the suppleness of the muscles and creating a deep sense of relaxation in body and mind. In the Ayurvedic tradition of India, which has gained popularity in the U.S. in recent years, steam treatments are part of the traditional purification treatment panchakarma, where they are used after massage to help the body get rid of toxins dislodged during the treatment.

Sweat treatments can also be enjoyed on their own, as a workout for the cardiovascular system, a deep-cleansing treat for the body, an immune system booster, and a soothing and invigorating refreshment for the mind.

There are a few precautions to keep in mind. Because of the increase in cardiovascular activity caused by the high heat, sweat therapy is not recommended for people with heart disease or other cardiovascular problems. Individuals with high blood pressure pressure should first consult their doctor.

In addition, the treatment is not advised for pregnant women, small children, or the elderly. Do not take a sweat treatment if you have a fever or an open wound. If you have been working out, be sure that your body has had time to cool down before exposing it to the heat of a sweat bath.

Limit treatment time to 10 to 15 minutes. Drink plenty of water of herbal tea before and after the sweat bath to replace fluids lost during the treatment. The sweat glands can secrete up to 30 grams of sweat per minute, or almost one pint per 15 minutes, so dehydration is a very real possibility, if you are not careful. Fatigue and other indications of dehydration can occur with as little as 1 to 2% loss in body weight.

The main thing to keep in mind is to enjoy the process. Do not push your body beyond its comfort level; the point is not to sweat it out the longest, but to allow your mind and body to luxuriate in this health-enhancing and invigorating miniature spa treatment.

Working up a sweat is one of our oldest folk remedies. "Give me an opportunity to create fever and I will cure any illness," said the Greek physician Paramenides two thousand years ago.
Today, besides creating a relaxing sense of well-being, relaxes and loosens muscles tissue, reducing daily buildup of tension and increasing muscle flexibility:
-boosts blood circulation, which helps aching and injured muscles to recover faster, because the stronger the flow of blood, the faster metabolic waste products are carried off. -stimulates vasodilatation of peripheral blood vessels, which relives pain and speeds healing of sprains and strains; -speeds up the metabolic processes of vital organs and endocrine glands resulting in a calorie loss of between 200 and 450 in a 20 minute session.

Part 5
According to Michael Marino, research associate at Lennox Hill Hospital's Institute of Sports Medicine and Athletic Trauma in New York City:
"….. heat exposure stimulates the hypothalamus, the gland that normally maintains and stabilizes body temperature to dissipate the excess heat. Heart rate increases as more blood flow is diverted from the inner organs towards the extremities of the skin. This automatic "cooling" reaction is actually a form of beneficial stress, a passive kind of cardiovascular exercise that helps to keep the body's system alert and functioning well."

The beneficial stress of heat on the heart is confirmed by physical fitness expert Bernard Gutin, Professor of Applied Physiology and Education at Teacher's College, Columbia University:
"Heat acts as a form of mostly beneficial stress on the body that produces physiological changes in heightened blood pressure, stepped-up heart rate and an increase in stress hormones."
According to Dr. Paavo Aviola, an author in health matters:

"The sauna increases the eliminative, detoxifying and cleansing capacity of the skin by stimulation of sweat glands. A steam bath provides a mild cleansing process for the skin as certain body fluids are released through the skin. It also promotes healthy skin tone and texture due to increased blood circulation."
more info at:

Sunday, November 12, 2006

Spleen Cells May Prove Effective Target for Lupus Treatment

(HealthDay News) -- Research done on mice specially bred to develop lupus has uncovered an area of the spleen that may give rise to the disease.

The area is called the marginal zone of the spleen and it appears that this is where B cells from the immune system go awry and turn into cells that attack the body's own tissues and organs, researchers say.

"This current work gives rise to new possibilities for targeted therapies that are perhaps much milder and more effective than current therapies," said the study's lead author, Thomas Enzler, a visiting scholar, internist and immunologist at the University of California, San Diego.

However, he was quick to add that it would be a long time before any such potential therapy could be available for humans.

Results of the study were published Thursday in the online edition of the journal Immunity.
Lupus is an autoimmune disease in which the immune system mistakenly attacks the body's tissues and organs. The disease can affect the joints, kidneys, lungs, brain, blood or skin.

As many as 1.5 million Americans have lupus, and the disease is far more common in women than in men, according to the Lupus Foundation of America (LFA).

Previously, researchers had developed a mouse version of lupus. These mice are bred to overproduce an immune system hormone (cytokine) known as B-cell activating factor (BAFF). In humans with lupus, the BAFF cytokine is often present in much higher-than-normal levels.

B cells produce antibodies. Normally, antibodies are produced to protect against viruses and bacteria. In the case of someone with lupus, however, the B cells produce autoreactive antibodies. This means the antibodies attack normal, rather than diseased, tissue.

When the mice overproduce BAFF, they develop lupus, though the mouse version isn't exactly the same as the human version.

The UCSD researchers transplanted some of the cells from the spleens of the marginal zone of the lupus mice into mice that didn't have their own B cells. Lupus-like antibodies began to develop in these mice immediately.

The researchers also removed the spleens of some of the lupus mice when they were in the early stages of developing the disease, or the scientists interrupted the production of the B cells. When they did this, lupus was diminished or prevented.

"It seems to be that the marginal zone is really important for developing autoimmune disease in transgenic mice," Enzler explained.

Dr. Joan Merrill, medical director of the Lupus Foundation of America and head of the clinical pharmacology research program at Oklahoma Medical Research Foundation, said, "This is an exciting scientific paper."

But, Merrill said, people with lupus shouldn't rush to their doctors to remove their spleens. "If a lupus patient has a splenectomy, the disease doesn't go away," she said, explaining that sometimes lupus patients have to have their spleens removed due to complications of the disease, and it doesn't cure lupus.

She also pointed out that this study was done in mice and the human immune system doesn't work in exactly the same way as the mouse immune system does.

Still, Merrill added that with this study and other research, "We're beginning to unravel some of the mysteries surrounding lupus, and I'm cautiously optimistic about the future. We're trying to find better targets and develop better and safer medicines."

More information
To learn more about lupus, visit the Lupus Foundation of America.

Wednesday, October 25, 2006

Behavioral Problems Common in Mentally Retarded Children

(HealthDay News) -- Behavioral and emotional problems are common among young people who are mentally retarded, and the incidence of such problems declines very slowly over the years, an Australian study finds.

Not much attention has been paid to these problems, ranging from cursing and head-banging to failure to communicate with other people, said researchers from the University of Sydney. But the study found that 41 percent of the young people they followed had such problems, and the incidence dropped by only about 1 percent a year over a 14-year period.

"Although it declined, the level remained relatively high," said Andrea M. Piccinin, who took part in the study and now is a research associate professor of human development and family sciences at Oregon State University. "We make the case that intervention and more understanding of the factors that would lessen psychopathology would be important."

The findings are published in the Oct. 25 issue of the Journal of the American Medical Association.

The study included 578 children and teens who were ages 5 to 19 at the start of the research in 1991. They were judged by the Developmental Behavior Checklist, a standard measure for children with what are formally called developmental disabilities.

"We looked at a global score and five subscales," Piccinin said. "The social relations subscale showed an increase. As these children come into adolescence and get older, there are more issues with their social relations, because they are in a situation where more is expected of them."

The decrease occurred in the scales that measured anxiety, communication ability, destructive behavior and general disturbance, she said. Overall, the incidence of problems was 30 percent at the end of the study.

The decrease in problems was greater in boys than girls over time, and the decrease was greater in those with mild retardation than in those with severe mental disability.

"The observation that severe psychopathology was already present in a high proportion of the cohort at commencement of the study, and the persistence of these symptoms, suggest the need for effective mental interventions," the researchers said. "This should include support, education and skills training for their parents, who are likely to be stressed by the burden of care."

Only 10 percent of the young people with behavioral and emotional problems received mental health interventions during the study, the researchers found.

"This points to the importance of intervention," Piccinin said.

More information
More on mental retardation is offered by the National Dissemination Center for Children With Disabilities.

Sunday, October 08, 2006

PTSD Can Take Months to Strike Wounded Iraq and Afghanistan Vets

(HealthDay News) -- Soldiers wounded during combat in Iraq and Afghanistan often develop post-traumatic stress disorder and depression months after getting out of a hospital, instead of soon after suffering their injuries, a new study found.

And the severity of the injuries also helps predict the risk of developing post-traumatic stress disorder (PTSD) or depression.

It's not clear why it's taking more than half a year, in some cases, for symptoms of PTSD and depression to emerge. However, the study authors speculated that the concentrated treatments and therapies offered in a hospital may temporarily ward off psychological problems, leaving them to surface once a soldier has been released and comes to realize the extent of the injuries.
The report was published in the October issue of The American Journal of Psychiatry.

"The rates of PTSD and depression are much lower immediately following the injury than what we were expecting," said lead researcher Dr. Thomas A. Grieger, of the Uniformed Services University of the Health Sciences and Walter Reed Army Medical Center, in Washington, D.C. "We were expecting rates of around 20 percent."

Instead, Grieger and his colleagues found the initial rate of PTSD and depression was 4 percent. The researchers expected the rates of PTSD and depression to be controlled early, as is often the case with victims of automobile accidents. "In contrast, in this [military] population, the rates went up instead of down with time," he said.

For the study, the researchers screened 613 soldiers, who were severely wounded between March 2003 and September 2004. Of those, 243 completed health assessments at one, four, and seven months after their injuries. The rates of PTSD were 4 percent at one month, 12 percent at four months, and 12 percent at seven months. Rates of depression were 4.4 percent at one month, 9 percent at four months, and 9 percent at seven months.

Grieger noted that 78 percent of those soldiers with PTSD or depression at seven months showed no signs of either condition at one month. "There is a need for ongoing evaluation of the individuals that have had these sorts of exposures," he said.

The reasons for these findings aren't clear, Grieger said. He noted, however, that soldiers in a hospital are getting psychiatric care and medication, which may not be continued after the soldiers leave. "It may be that these symptoms come on after they leave the hospital because they are not continuing with their medications," he said. "It may also be that individuals don't report symptoms in the immediate aftermath of the injury."

Grieger further speculated that it's only when the soldiers return home and realize the full impact of their injuries on their lives that PTSD and depression strike.

One expert thinks this study could be helpful in designing programs to prevent and treat PTSD and depression in military personnel.

"Being wounded is a risk factor for PSTD," said Dr. Matthew J. Friedman, executive director of the Department of Veterans Affairs National Center for Post-Traumatic Stress Disorder.
Friedman believes it's important to understand why some soldiers recover from PTSD and depression when they struggle with it early, and why others develop these problems later. "This would enable us to do a better job of developing preventive approaches and trying to improve the situation for people following hospital discharge," he said.

Another researcher noted the rates of PTSD and depression seen among wounded soldiers returning from Iraq and Afghanistan are about the same as those seen among non-wounded soldiers.

"One of the important findings is that wounded soldiers did not have higher rates of PTSD than healthy soldiers surveyed using the same instruments and criteria," said Dr. Charles Hoge, who's with the department of psychiatry and behavioral sciences at Walter Reed Army Institute of Research. "This suggests that the preventive psychiatry services that wounded service members receive at Walter Reed has been effective in mitigating PTSD symptoms."

"The increase from 4 to 12 percent from one to four months is exactly what we've been seeing among non-wounded soldiers," Hoge added, who co-authored the new study. "We know that soldiers may not report mental-health symptoms until several months after they return home, and this study shows that this is true also among the wounded."

More information
The U.S. National Institute of Mental Health can tell you more about PTSD.

Monday, October 02, 2006

Weight Gain Between Pregnancies Poses Health Risks

(HealthDay News) -- Weight gain between a woman's first and second pregnancies can cause complications during pregnancy and delivery -- even for women not considered medically overweight, a new study found.

While previous studies had noted an association between weight gain and pregnancy complications, this new research is the best evidence thus far for a cause-and-effect relationship, the researchers said.

"We are contributing evidence to strengthen the argument for causality," said Dr. Eduardo Villamor, assistant professor of international nutrition at the Harvard School of Public Health and lead author of the study, which was published in the Sept. 30 issue of The Lancet. "As far as we could humanly show, the evidence is pretty robust," he said.

The practical implications are clear. "Being of normal weight and trying to lose weight between pregnancies would be very helpful," added Dr. Ellen Landsberger, assistant professor of obstetrics and gynecology and women's health at Albert Einstein College of Medicine in New York City, who also has a degree in nutrition.

Paradoxically, another new study found that women who had regularly exercised for four or more hours a week in the previous nine years or less were 40 percent less likely to have a live birth after their first cycle of in-vitro fertilization, compared to women who didn't exercise.

The study also found that regular exercisers were twice as likely to have an implantation failure or pregnancy loss after undergoing in-vitro fertilization (IVF). Cardiovascular exercise, in particular, was associated with a 30 percent lower likelihood of successful live birth compared with women who didn't exercise. It was unclear why this was the case, although hormones certainly could be involved, the authors theorized.

This study, by researchers at Brigham and Women's Hospital in Boston, was published in the October issue of the journal Obstetrics & Gynecology.

Overweight and obesity have become one of the world's greatest public-health challenges. In the United States in 1999-2000, 28 percent of women aged 20 to 39 were obese, up from only 9 percent in 1960-62.

And some relationship, whether causal or not, between overweight and obesity and pregnancy complications has long been suspected.

For the new study, investigators from Harvard and Sweden took advantage of Sweden's excellent health records, studying more than 150,000 Swedish women with first and second births between 1992 and 2001.

Body mass index (BMI, a ratio of weight to height) was calculated at the first prenatal visit of each pregnancy. The difference in BMI was then correlated with complications during second pregnancies, including preeclampsia (hypertension), gestational diabetes, gestational hypertension and Caesarean delivery as well as stillbirth and large-for-gestational-age birth.
A gain of one to two BMI units increased the risk of gestational diabetes, gestational hypertension or large-for-gestational age birth an average of 20 percent to 40 percent. A gain of three or more BMI units resulted in a 63 percent greater chance of stillbirth compared to a gain of less than one BMI unit. It also had a greater effect on all other complications, the researchers found.

Even modest amounts of weight gain in normal-sized women caused problems. If a 5-foot-5-inch woman weighting 139 pounds (a BMI of 23, considered normal) gained 6.6 pounds -- or one BMI unit -- between the two pregnancies, her average risk of gestational diabetes increased more than 30 percent. A gain of 12.2 pounds (two BMI units) increased the risk 100 percent.
"One of the key findings of our study is that we found that weight gain between pregnancies increased the risk of these complications even in women who had never been obese or overweight," Villamor said.

"It appears it is not necessary for women to become overweight or obese, a few kilos might carry a risk," he continued. "One message could be that women should not gain any weight. They should try to go back to their pre-pregnant weight and should not gain any weight after the first pregnancy. Obviously, overweight and obese women should try to reduce their weight and that's likely accompanied by other health benefits."

More information
To calculate your BMI, visit the National Heart, Lung, and Blood Institute.

Weight Loss Ebook - Secrets Revealed - Revised Edition

Weight Loss Ebook - Secrets Revealed - Revised Edition

$19.95
[ learn more ]

Add to Cart

This is not only a weight loss program, it is also a plan for "TOTAL HEALTH". If you want a quick fix (taking metabolism boosters, etc.), only to gain more weight when you stop, do not even consider this program. Our program is designed to change the way you think and live your life. Change is only a decision away. You can do this! If you are motivated, and truly care about taking care of your body, and you are willing to make changes in your life, then this program is for you! - E-Book Version.(WL)

Thursday, September 07, 2006

Protein Predicts Lung Cancer's Response to Treatment

(HealthDay News) -- Levels of a protein linked to cellular DNA repair can predict how well non-small-cell lung cancer patients will respond to cisplatin, a common chemotherapy.

So concludes a French study published in the Sept. 7 New England Journal of Medicine.
Patients with low levels of the protein marker, called ERCC1, "will have a very significant level of benefit from adjuvant cisplatin-based chemotherapy," said lead researcher Dr. Jean-Charles Soria, from the Department of Medicine, Institute Gustave Roussy, Villejuif.

Cisplatin is a standard component of chemotherapy for lung and other cancers; however, not everyone benefits from the drug. This new study suggests that screening for levels of the ERCC1 protein in lung biopsies can help doctors determine who will benefit from the treatment and who will not.

According to the American Cancer Society, lung cancer accounts for 13 percent of all new cancers and is the leading cancer killer of American men and women. Non-small cell cancers comprise 85 percent of the nearly 175,000 new cases of lung cancer diagnosed in the United States each year.
In their study, Soria's group looked at 761 lung cancer tumors. Of these, 44 percent had high levels of ERCC1, and 56 percent had low levels of the protein.

They found that patients who had low levels of ERCC1 benefited from cisplatin treatment, which helped extend life for these patients.

However, this was not the case among patients with high levels of ERCC1.
These patients "do not derive benefit from adjuvant chemotherapy, and if not treated, they do have a better 'spontaneous' prognosis than those who are ERCC1-negative," Soria said.

The French researcher believes that ERCC1 screening could spot those most likely to benefit from cisplatin treatment. "In our study, ERCC1 expression was evaluated by means of immunohistochemistry" of tissues in the laboratory, he said. "This is a simple technique, reliable, cheap and widely applicable," he added.

Screening patients might also help determine individual reaction to treatment, he added. "The goal of providing individualized chemotherapy based on different genetic traits, such as polymorphisms, gene mutations, and overexpression of drug target proteins, is on the verge of becoming clinical practice for the benefit of cancer patients," Soria said.

Two other experts agreed that ERCC1 screening should become part of a standard assessment of how patients might react to platinum-based chemotherapy, such as cisplatin.

"In my view, it's time to begin to think about whether or not we should begin to use this information to screen patients," said Dr. Eddie Reed, the director of the Division of Cancer Prevention and Control at the U.S. Centers for Disease Control and Prevention, and the author of an accompanying journal editorial.

Reed believes that ERCC1 screening for other cancer where cisplatin is commonly used -- such as ovarian and colorectal cancer -- needs to be examined, as well. "It's time to consider whether or not we should use this strategy," he said.

Dr. Norman Edelman, chief medical officer for the American Lung Association, agreed.
ERCC1 screening "is something that could save a substantial number of patients a substantial amount of discomfort," he said.

More information
Find out more about lung cancer at the American Cancer Society.

Friday, August 25, 2006

Gruff-f-f Love

(HealthDay News) -- Puppy love in a nursing home?
That's the upshot of a new study that found nursing-home residents who had regular visits from a dog felt better and less lonely -- better, in fact, than after visits with a dog and other people.
Researcher Marian Banks, a registered nurse, and her dog Sparky, a friendly Welsh corgi mix, visited 37 residents at three long-term care facilities in St. Louis who scored high on a loneliness scale.
Half the residents spent 30 minutes alone each week with Sparky. They were allowed to interact with the small dog without any interference or input from Banks.
The other half visited Sparky with one to three other nursing home residents present. Participants sat in a circle and could interact with the dog and other residents.
Initially, the researchers thought the dog would act like a "social lubricant" and increase interaction between residents, thereby reducing their feelings of loneliness.
But that wasn't the case.
"It was a strange finding," said William Banks, professor of geriatrics at Saint Louis University School of Medicine and co-author of the study. "We expected the group dog visits were going to work better but they didn't."
Instead, the residents, ranging in age from 75 to 90, found that some quiet time with a furry friend was a lot nicer.
The study suggests that pets make people in nursing homes feel better by simply being with them, not by enhancing socialization between other residents, the researchers said.
"A big percentage of the individuals that had Sparky on a one-on-one basis had a tremendous drop in their level of loneliness as measured by the UCLA loneliness scale," Marian Banks said.
The study also found that the loneliest individuals benefited the most from the canine companionship.
The research will appear in the March issue of Anthrozoos, a journal that focuses on human-animal interaction.
The majority of nursing-home residents who participated in the study had pets during their childhood and adult years.
Marian Banks said the residents who spent time alone with Sparky confided in him and reminisced a great deal, talking about previous experiences with pets.
Sandy Ransom is vice president of the board of directors for the Eden Alternative, whose goal is to offer a more enriching environment in nursing homes, in part, by allowing pets to be kept at the facilities.
She said she wasn't surprised by the study findings.
"I think it gives validity to what we've known all along" she said.
The Eden Alternative has programs in place at 300 nursing homes across the country. Residents participate in caring for the animals, giving meaning to their lives and relief from loneliness, Ransom said.
"We haven't done a scientific study on (the impact of pets on residents) but some things you really don't need numbers," she said. "You can just see that people are doing a lot better."
Loneliness is a common problem for people in long-term care facilities, often due to the loss of loved ones and independence, health-care experts say.
While Ransom is an advocate for keeping pets full time in long-term facilities, she doesn't like the idea of bringing them in for visits.
"We feel that animal-assisted therapy, in essence, is sort of cruel to the elders because you give them something that they can't have and then you take it away," she said. "That's why we believe in resident animals for people who choose to have them."
More information
The National Library of Medicine has more about nursing homes.

Saturday, August 12, 2006

Hectic Days Leave Fleeting Memories

WEDNESDAY, July 26 (HealthDay News) -- No wonder many busy people can't recall what they did yesterday.
A new study finds that learning while multi-tasking results in less available memory, later on, of the item learned.
"If you're learning things under distraction, what you're going to end up learning is going to be different and, in particular, is going to be a lot less flexible," said Russell Poldrack, senior author of the study and associate professor of psychology at the University of California, Los Angeles. "Less flexible," in this case, means that the memory "will be more tied to the specific circumstances of when you learned it," and less prone to recall when those circumstances change, Poldrack said.
His team reported its findings in the current issue of Proceedings of the National Academy of Sciences.
Experts had already known that different forms of memory are processed by different systems in the brain.
"For the past 25 years, we have made great advances in delineating the different memory systems in the human brain," said Anthony Wagner, assistant professor of psychology and neuroscience at Stanford University. "Extensive data has shown that there is not a single learning memory system but actually multiple memory systems," he said.
Declarative memory, for instance, is the ability to recall lived experience, such as what you had for breakfast.
Procedural memories are more about learning how to do things, such as playing tennis or solving math problems.
"The fundamental questions beginning to capture the field are whether [these systems] interact and how they interact," Wagner said.
Poldrack's lab hypothesized that declarative and procedural memory might actually compete with each other.
To test that hypothesis, the researchers looked at how distraction or multi-tasking might cause a person to rely less on declarative memory and more on procedural memory.
That difference can be important. "Declarative memory is much more flexible," Poldrack explained. "If I ask you what you had for breakfast, it doesn't matter where you're standing. But if I ask you for a phone number, you might have to punch the numbers out with fingers. That's the only way you know how to do it."
In the study, Poldrack and his colleagues showed 14 adult volunteers cards with shapes on them and asked the volunteers to categorize the cards into one of two categories. Participants first performed the task on its own, and then again while doing something else at the same time. All the tasks were performed while participants were in an MRI scanner, so that the researchers could observe brain function.
Poldrack's group found that the things learned without distraction involved the declarative memory system.
On the other hand, "Things learned under distraction rely more on brain regions involved in procedural memory," Poldrack said. Those types of memories are tougher to bring up once the setting changes.
So, the bottom line for busy people is that, "When we learn to do things while we're multi-tasking, we're changing how our brain learns and the kind of knowledge we end up with," he continued. "It's not necessarily a good change. Our knowledge becomes less flexible, or tied to that particular situation, so we can't get to it in other situations."
Wagner said the study "supports the position that declarative memory would be hindered by divided attention."
More information
For more on memory and memory loss, head to the American Academy of Family Physicians.
Last reviewed: 07/26/2006 Last updated: 07/26/2006

Hectic Days Leave Fleeting Memories

WEDNESDAY, July 26 (HealthDay News) -- No wonder many busy people can't recall what they did yesterday.
A new study finds that learning while multi-tasking results in less available memory, later on, of the item learned.
"If you're learning things under distraction, what you're going to end up learning is going to be different and, in particular, is going to be a lot less flexible," said Russell Poldrack, senior author of the study and associate professor of psychology at the University of California, Los Angeles. "Less flexible," in this case, means that the memory "will be more tied to the specific circumstances of when you learned it," and less prone to recall when those circumstances change, Poldrack said.
His team reported its findings in the current issue of Proceedings of the National Academy of Sciences.
Experts had already known that different forms of memory are processed by different systems in the brain.
"For the past 25 years, we have made great advances in delineating the different memory systems in the human brain," said Anthony Wagner, assistant professor of psychology and neuroscience at Stanford University. "Extensive data has shown that there is not a single learning memory system but actually multiple memory systems," he said.
Declarative memory, for instance, is the ability to recall lived experience, such as what you had for breakfast.
Procedural memories are more about learning how to do things, such as playing tennis or solving math problems.
"The fundamental questions beginning to capture the field are whether [these systems] interact and how they interact," Wagner said.
Poldrack's lab hypothesized that declarative and procedural memory might actually compete with each other.
To test that hypothesis, the researchers looked at how distraction or multi-tasking might cause a person to rely less on declarative memory and more on procedural memory.
That difference can be important. "Declarative memory is much more flexible," Poldrack explained. "If I ask you what you had for breakfast, it doesn't matter where you're standing. But if I ask you for a phone number, you might have to punch the numbers out with fingers. That's the only way you know how to do it."
In the study, Poldrack and his colleagues showed 14 adult volunteers cards with shapes on them and asked the volunteers to categorize the cards into one of two categories. Participants first performed the task on its own, and then again while doing something else at the same time. All the tasks were performed while participants were in an MRI scanner, so that the researchers could observe brain function.
Poldrack's group found that the things learned without distraction involved the declarative memory system.
On the other hand, "Things learned under distraction rely more on brain regions involved in procedural memory," Poldrack said. Those types of memories are tougher to bring up once the setting changes.
So, the bottom line for busy people is that, "When we learn to do things while we're multi-tasking, we're changing how our brain learns and the kind of knowledge we end up with," he continued. "It's not necessarily a good change. Our knowledge becomes less flexible, or tied to that particular situation, so we can't get to it in other situations."
Wagner said the study "supports the position that declarative memory would be hindered by divided attention."
More information
For more on memory and memory loss, head to the American Academy of Family Physicians.
Last reviewed: 07/26/2006 Last updated: 07/26/2006

Monday, July 10, 2006

Holocaust Survivors at Higher Long-Term Cancer Risk

(HealthDay News) -- A new study finds that rates of cancer and cancer-related death are especially high among survivors of the Holocaust in Israel.

An Israeli research team found that Holocaust survivors who emigrated from Europe to Israel following World War II are at higher risk for cancer compared to European Jews who moved there before the war began.

Much of the difference can be attributed to cancers found among the youngest Holocaust survivors. Specifically, male and female immigrants born in Europe between 1940 and 1945 faced the highest odds of developing breast or colorectal cancers, the researchers found.
While the findings may have implications for survivors of mass atrocities in general, they are of immediate concern to the 238,600 Holocaust survivors still living in Israel, said study co-author Dr. Micha Barchana.

"The bad news is that Holocaust survivors are at a higher risk to get cancer, but the good news is that we can do something [about it]," he said. "We are focusing on the practical implementation of the research results: the need for survivors to participate in early-detection programs that are offered in Israel as well as in most modern countries, due to the finding that classifies them as a high-risk population," he explained.

Barchana serves as the director of the National Cancer Registry in the Israeli Health Ministry and is also a senior lecturer in the school of public health at the University of Haifa in Israel.
He and his colleagues presented their research earlier this year at the International Agency for Research on Cancer, held in Lyon, France.

The work was funded by the Israel Cancer Society.
Barchana's team reviewed records from the Israeli government's Central Bureau of Statistics to first draft a list of all Jewish immigrants to Israel born in Europe between 1920 and 1945.
They then turned to the Israeli Health Ministry's National Cancer Registry to compile cancer incidence and death rates among these immigrants.

The researchers found that those immigrants born between 1920 and 1945 who came to Israel between the end World War II and 1989 were at significantly higher risk for cancer than immigrants born between 1920 and 1939 who migrated to Israel before the onset of World War II.

Barchana said his team does not know how many of the post-war European immigrants suffered through the experience of Nazi concentration camps or wartime Jewish ghettos. However, he said his team assumed that many or most did, and that, in any case, "all the Jews in Europe at war time had gone through severe food deprivation and other stresses."

Higher cancer risks seemed to linger for decades for this group, the researchers found. Male Holocaust survivors experienced a 14 percent higher cancer incidence rate than pre-war immigrants and were 2.4 times more likely to get cancer than their pre-war compatriots.

Female Holocaust survivors had a 21 percent higher rate of cancer than pre-war immigrants and were 2.3 times more likely to have a cancer diagnosis than pre-war immigrants.

Breaking down cancer incidence by specific diseases, the authors found that Holocaust survivors were at a significantly higher risk for lung cancer, Kaposi's sarcoma (a rare form of skin malignancy), and prostate cancer.

Heightened risks for certain other cancers stood out. For example, male Holocaust survivors were nine times more likely to be diagnosed with cancer of the large intestine than pre-war immigrants. Female Holocaust survivors faced more than double the risk for cancer of the large intestine and a 50 percent higher risk of developing breast cancer, the study found.

In addition, Barchana's team found that the younger the Holocaust survivor was during the war, the greater their risk for getting cancer. In fact, most of the increase in risk among Holocaust survivors was borne by those who were 14 years of age or younger during World War II.

Barchana said that finding has been shown in other studies involving survivors of terrible events. "Research on A-bomb survivors in Japan clearly shows that women that were at a young age are at higher risk of developing cancer later in life," he said. Similar data is emerging among those affected by the Chernobyl nuclear plant accident, Barchana added.

Patients who had survived the Holocaust also had a tougher battle to fight off the disease once it was diagnosed, the researchers found. According to Barchana, that may be due to the fact that "Holocaust survivors are being diagnosed at later stages compared to the control group."

Five-year cancer survival rates were 5 percent to 13 percent lower among Holocaust survivors compared to other immigrants, regardless of sex or age.

According to the researchers, the findings suggest that severe deprivation, from whatever cause, may weaken the body's long-term defenses against cancer. Inmates in the Nazi concentration camps suffered prolonged exposure to extreme poverty, food deprivation, over-crowding, harsh weather, physical abuse and mental stress.

The authors called for Holocaust survivors and their families to be increasingly vigilant about cancer detection, particularly for breast and colorectal cancers, and to avail themselves of the free screenings for such diseases that are currently available in Israel.

On a wider note, Barchana emphasized the role that food deprivation probably plays as a contributing factor to increased cancer risk.

"There has been some (prior) data on the possible role of malnutrition in breast cancer etiology," he remarked. "This work completes this knowledge, and this aspect of the study should be further investigated," Barchana said.

Dr. Michael Thun, vice president of epidemiology and surveillance research with the American Cancer Society in Atlanta, said the study was interesting and, in some ways, surprising.

"When one compares these results to studies of the Dutch Famine of 1944 to 1945, what they had found was that there was an increase in breast cancer risk, but they did not find the same increase in other cancers," Thun noted. "So, in this study, it was surprising to me that there was an increase in risk in colorectal cancer and a range of different cancers," he said.

"But in the case of the Holocaust, people had so many terrible things happen that it's even more complex and dreadful than just the famine resulting from war," added Thun. "So, I agree with the authors' conclusions that closer screening of these people is warranted to detect cancers early," he said.

More information
For advice on cancer screening, visit the American Cancer Society.

Tuesday, July 04, 2006

The finding demonstrates for the first time that diallyl sulfide triggers a gene alteration in PhIP

"The finding demonstrates for the first time that diallyl sulfide triggers a gene alteration in PhIP that may play a significant role in preventing cancer, notably breast cancer, induced by PhIP in well-done meats," the researchers reported.

All of these findings come on the heels of a sixth study, reported in last week's issue of The Lancet, which found that people with a genetic susceptibility to lung cancer could cut their risk for the disease by eating vegetables from the cabbage family.

"We found protective effects with at least weekly consumption of cruciferous vegetables," says lead researcher Paul Brennan of the International Agency for Research on Cancer in Lyon, France.

One expert says the results of the six studies are interesting. And while it may be some time before they have any practical applications for people, that should not stop us from adding more vegetables and fruits to our diet. "An extensive body of epidemiologic evidence suggests consistently, if not decisively, that generous consumption of fruits and vegetables is associated with reduced cancer risk," says Dr. David L. Katz, an associate professor of public health and director of the Prevention Research Center at Yale University School of Medicine.

Further study should provide "a clearer picture both of what foods reduce cancer risk, and how," Katz says. "Understanding in each of these areas will lead to new insights in the other. A refined ability to use diet in the prevention of cancer will ensue. "That is an exciting prospect," he adds. "But excitement about what may come should not distract from what is already in hand. Even with gaps in our knowledge, the case for increasing fruit and vegetable consumption to promote health and prevent disease -- cancer included -- is compelling and strong."
(The HealthDay Web site) 2005 HealthDay News

ClickComments

Balancing Your Hormones Without Drugs... You Can Feel Good Again

Balancing Your Hormones Without Drugs... You Can Feel Good Again

$19.95
[ learn more ]

Add to Cart

Hormone imbalance can be reversed! Look and feel better than ever, just take the time to learn about yourself and read the information contained in this just released e-book about reversing hormone imbalance. Are you ready to finally look and feel great? If so... read on... - E-Book Version.(BH)